Boxer Capital as of March 31, 2020
Portfolio Holdings for Boxer Capital
Boxer Capital holds 62 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Mirati Therapeutics | 9.3 | $136M | 1.8M | 76.87 | |
| Immunomedics | 7.8 | $114M | 8.5M | 13.48 | |
| Beigene (ONC) | 7.8 | $114M | 925k | 123.11 | |
| Odonate Therapeutics Ord | 6.3 | $93M | 3.4M | 27.61 | |
| Revolution Medicines (RVMD) | 4.6 | $67M | 3.0M | 21.91 | |
| Regeneron Pharmaceuticals (REGN) | 4.5 | $66M | 135k | 488.29 | |
| Springworks Therapeutics (SWTX) | 3.8 | $56M | 2.1M | 27.00 | |
| Black Diamond Therapeutics (BDTX) | 3.4 | $50M | 2.0M | 24.95 | |
| Seattle Genetics | 3.1 | $46M | 400k | 115.38 | |
| Sage Therapeutics (SAGE) | 3.0 | $44M | 1.5M | 28.72 | |
| Arcus Biosciences Incorporated (RCUS) | 2.9 | $43M | 3.1M | 13.88 | |
| Uniqure Nv (QURE) | 2.5 | $36M | 765k | 47.45 | |
| Esperion Therapeutics (ESPR) | 2.1 | $31M | 975k | 31.53 | |
| Allakos | 2.0 | $30M | 675k | 44.49 | |
| Passage Bio | 2.0 | $30M | 1.9M | 15.75 | |
| Atreca Inc Cl A (BCEL) | 2.0 | $29M | 1.7M | 16.55 | |
| Dbv Technologies S A | 1.9 | $28M | 7.0M | 3.92 | |
| Argenx Se (ARGX) | 1.8 | $26M | 200k | 131.73 | |
| Kadmon Hldgs | 1.8 | $26M | 6.2M | 4.19 | |
| Gossamer Bio (GOSS) | 1.5 | $22M | 2.2M | 10.15 | |
| Amicus Therapeutics (FOLD) | 1.5 | $22M | 2.3M | 9.24 | |
| BioMarin Pharmaceutical (BMRN) | 1.4 | $21M | 250k | 84.50 | |
| Rocket Pharmaceuticals (RCKT) | 1.4 | $21M | 1.5M | 13.95 | |
| Anaptysbio Inc Common (ANAB) | 1.3 | $18M | 1.3M | 14.13 | |
| Bellus Health | 1.2 | $18M | 1.8M | 9.98 | |
| Direxion Shs Etf Tr Daily S&p Biotec | 1.2 | $18M | 1.3M | 14.08 | |
| Compugen (CGEN) | 1.2 | $17M | 2.4M | 7.26 | |
| Trillium Therapeutics, Inc. Cmn | 1.1 | $17M | 4.1M | 4.04 | |
| ACADIA Pharmaceuticals (ACAD) | 1.1 | $16M | 370k | 42.25 | |
| Ipath Series B S&p500 Vix | 0.9 | $14M | 300k | 46.25 | |
| Prevail Therapeutics Ord | 0.9 | $14M | 1.1M | 12.19 | |
| Global Blood Therapeutics In | 0.9 | $13M | 250k | 51.09 | |
| Neoleukin Therapeutics | 0.8 | $12M | 1.0M | 11.38 | |
| Cabaletta Bio (CABA) | 0.8 | $11M | 1.6M | 7.30 | |
| Relmada Therapeutics (RLMD) | 0.7 | $10M | 300k | 34.11 | |
| Agenus | 0.7 | $9.8M | 4.0M | 2.45 | |
| Marinus Pharmaceuticals | 0.7 | $9.7M | 4.8M | 2.03 | |
| Amarin Corporation | 0.6 | $9.0M | 2.3M | 4.00 | |
| Akero Therapeutics (AKRO) | 0.6 | $8.8M | 417k | 21.20 | |
| Axsome Therapeutics (AXSM) | 0.6 | $8.8M | 150k | 58.83 | |
| Kura Oncology (KURA) | 0.6 | $8.4M | 845k | 9.95 | |
| Syndax Pharmaceuticals (SNDX) | 0.5 | $8.0M | 726k | 10.97 | |
| Selecta Biosciences | 0.5 | $7.9M | 3.3M | 2.41 | |
| Kodiak Sciences (KOD) | 0.5 | $7.2M | 150k | 47.70 | |
| Matinas Biopharma Holdings, In | 0.5 | $6.9M | 12M | 0.60 | |
| Xenon Pharmaceuticals (XENE) | 0.5 | $6.8M | 600k | 11.34 | |
| Mei Pharma | 0.3 | $4.7M | 2.9M | 1.61 | |
| Artara Therapeutics | 0.3 | $4.6M | 200k | 23.00 | |
| Kiniksa Pharmaceuticals | 0.3 | $4.5M | 291k | 15.48 | |
| Mirum Pharmaceuticals (MIRM) | 0.3 | $4.4M | 317k | 14.00 | |
| Zogenix | 0.3 | $4.3M | 175k | 24.73 | |
| La Jolla Pharmaceuticl Com Par | 0.3 | $3.7M | 891k | 4.20 | |
| Solid Biosciences | 0.2 | $3.7M | 1.5M | 2.39 | |
| Barclays Bk Plc cmn | 0.2 | $3.5M | 75k | 46.25 | |
| Ideaya Biosciences (IDYA) | 0.2 | $3.1M | 764k | 4.12 | |
| Lifesci Acquisition Corp unit 03/31/2025 | 0.2 | $3.0M | 300k | 10.00 | |
| Cymabay Therapeutics | 0.2 | $3.0M | 2.0M | 1.48 | |
| Mereo Biopharma Group Plc ads (MREO) | 0.2 | $2.6M | 2.5M | 1.05 | |
| Milestone Pharmaceuticals (MIST) | 0.1 | $2.0M | 1.1M | 1.84 | |
| Cellectar Biosciences | 0.1 | $1.2M | 920k | 1.33 | |
| Bellerophon Therapeutics | 0.1 | $1.1M | 99k | 10.96 | |
| Zymeworks | 0.1 | $887k | 25k | 35.48 |
